OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

· TechCrunch AI ·

An OpenAI researcher is reportedly raising for an AI drug discovery startup at a $2B valuation, signaling investor demand for AI biotech.

Categories: Money & Moves

Excerpt

Lightspeed is in discussions to lead the funding round, sources say.